SYMPROIC Trademark

Trademark Overview


On Tuesday, January 27, 2015, a trademark application was filed for SYMPROIC with the United States Patent and Trademark Office. The USPTO has given the SYMPROIC trademark a serial number of 79168243. The federal status of this trademark filing is Section 71 & 15 - ACCEPTED AND ACKNOWLEDGED as of Tuesday, May 24, 2022. This trademark is owned by SHIONOGI & CO., LTD.. The SYMPROIC trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment and prevention of cardiovascular diseases, diabetes, obesity, cancer, endocrine disorders, hormonal diseases and disorders, urological disorders, sexual dysfunction, HIV and AIDs, central nervous systems diseases and disorders, peripheral nervous system diseases and disorders, osteoporosis, rheumatism, neurological disorders, pain, gastrointestinal disorders, respiratory diseases and disorders, allergies, bacterial disorders, viral disorders, fungal disorders, infectious diseases, inflammation and inflammatory diseases, sepsis, immunological disorders, musculoskeletal disorders, disease and disorders of the liver, allergic rhinitis, and thrombocytopenia; pharmaceutical preparations for treating opioid-induced constipation
symproic

General Information


Serial Number79168243
Word MarkSYMPROIC
Filing DateTuesday, January 27, 2015
Status739 - Section 71 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateTuesday, May 24, 2022
Registration Number4887392
Registration DateTuesday, January 19, 2016
Mark Drawing5 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, November 3, 2015

Trademark Statements


Description of MarkThe mark consists of the stylized wording "SYMPROIC".
Goods and ServicesPharmaceutical preparations for the treatment and prevention of cardiovascular diseases, diabetes, obesity, cancer, endocrine disorders, hormonal diseases and disorders, urological disorders, sexual dysfunction, HIV and AIDs, central nervous systems diseases and disorders, peripheral nervous system diseases and disorders, osteoporosis, rheumatism, neurological disorders, pain, gastrointestinal disorders, respiratory diseases and disorders, allergies, bacterial disorders, viral disorders, fungal disorders, infectious diseases, inflammation and inflammatory diseases, sepsis, immunological disorders, musculoskeletal disorders, disease and disorders of the liver, allergic rhinitis, and thrombocytopenia; pharmaceutical preparations for treating opioid-induced constipation
Indication of Colors claimedColor is not claimed as a feature of the mark.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, July 7, 2015
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSHIONOGI & CO., LTD.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressOsaka-shi, Osaka 541-0045
JP

Party NameSHIONOGI & CO., LTD.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressOsaka 541-0045
JP

Party NameSHIONOGI & CO., LTD.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressOsaka 541-0045
JP

Trademark Events


Event DateEvent Description
Monday, July 6, 2015LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, July 2, 2015SN ASSIGNED FOR SECT 66A APPL FROM IB
Tuesday, September 1, 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, September 17, 2015ASSIGNED TO LIE
Thursday, September 24, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, July 7, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, July 7, 2015ASSIGNED TO EXAMINER
Wednesday, July 8, 2015NON-FINAL ACTION WRITTEN
Thursday, July 9, 2015NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, July 10, 2015REFUSAL PROCESSED BY MPU
Friday, July 10, 2015NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Saturday, July 11, 2015APPLICATION FILING RECEIPT MAILED
Saturday, August 1, 2015REFUSAL PROCESSED BY IB
Thursday, September 24, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, September 29, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, September 29, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, October 14, 2015NOTICE OF PUBLICATION
Tuesday, November 3, 2015PUBLISHED FOR OPPOSITION
Tuesday, April 19, 2016FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Friday, April 22, 2016FINAL DISPOSITION NOTICE SENT TO IB
Friday, May 13, 2016FINAL DECISION TRANSACTION PROCESSED BY IB
Tuesday, January 19, 2016REGISTERED-PRINCIPAL REGISTER
Friday, April 22, 2016FINAL DISPOSITION PROCESSED
Tuesday, May 24, 2022NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
Thursday, November 11, 2021TEAS SECTION 71 & 15 RECEIVED
Monday, May 23, 2022CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, May 24, 2022REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
Thursday, December 19, 2024INTERNATIONAL REGISTRATION RENEWED
Sunday, January 19, 2025COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED